bloomberg.com
Ginkgo Agrees to $17.5 Billion Merger With Harry Sloan SPAC
Ginkgo Bioworks Inc., which calls itself an “organism design” company, has agreed to go public in a $17.5 billion merger with a blank-check firm backed by former Hollywood executive Harry Sloan.